Is transvaginal ultrasound (TVUS) more effective than other imaging modalities for evaluating abnormal uterine bleeding (AUB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Transvaginal ultrasound, combined with transabdominal ultrasound of the pelvis with Doppler, is the most appropriate initial imaging study for patients with abnormal uterine bleeding. This approach is supported by the American College of Radiology Appropriateness Criteria, which are evidence-based guidelines that are reviewed annually by a multidisciplinary expert panel 1. The use of transvaginal ultrasound provides superior visualization of the endometrium, myometrium, and other pelvic structures due to the closer proximity of the ultrasound probe to these organs.

When evaluating abnormal uterine bleeding, transvaginal ultrasound can accurately measure endometrial thickness, detect endometrial polyps, fibroids, adenomyosis, and identify structural causes of bleeding. The procedure involves inserting a probe into the vagina while the patient has an empty bladder, which is more comfortable than the full bladder required for transabdominal ultrasound. Key benefits of this approach include:

  • Improved resolution for better characterization of endometrial abnormalities
  • More accurate measurements, which are crucial for determining appropriate management of abnormal uterine bleeding
  • The ability to detect a range of conditions that may be causing the abnormal bleeding, allowing for targeted treatment plans

According to the guidelines, if the uterus is incompletely visualized with the initial ultrasound, MRI of the pelvis without and with contrast is the next appropriate imaging study, unless a polyp is suspected on the original ultrasound, then sonohysterography can be performed 1. This stepped approach ensures that patients receive the most appropriate imaging for their specific condition, minimizing unnecessary tests and procedures.

From the Research

Assessment of Abnormal Uterine Bleeding

  • Transvaginal ultrasound is considered the first-line imaging test for evaluating abnormal uterine bleeding in both premenopausal and postmenopausal women 2.
  • It can diagnose structural causes of abnormal bleeding, such as polyps, adenomyosis, leiomyomas, hyperplasia, and malignancy, and can also be beneficial in making the diagnosis of ovulatory dysfunction 2.

Comparison with Other Imaging Techniques

  • Transvaginal ultrasound plays a pivotal role in the management of non-pregnant women with abnormal vaginal bleeding, with no other imaging technique having a role in the triage of these women 3.
  • While transvaginal ultrasound may not be able to diagnose all causes of abnormal vaginal bleeding before menopause, such as infection or problems with intrauterine contraceptive devices, it can still be helpful in some cases 3.

Diagnostic Accuracy

  • The diagnostic accuracy of transvaginal ultrasound in detecting endometrial polyps can be improved with the addition of saline infusion sonohysterography (SIS) 4.
  • Even when diagnostic confidence for the presence of polyps is high, SIS has a higher positive predictive value than transvaginal ultrasound alone 4.

Clinical Application

  • Transvaginal ultrasound can be used to plan surgical procedures, such as hysteroscopy or laparotomy, and can help determine when no further surgical evaluation is necessary 5.
  • A structured transvaginal ultrasound approach can be implemented in clinical practice to simplify the diagnosis of abnormal uterine bleeding and determine when additional invasive investigations are required 6.

Related Questions

Is transvaginal ultrasound or transabdominal ultrasound better for evaluating uterine pathology?
In a 41-year-old woman with six months of abnormal uterine bleeding who desires contraception, what is the most important investigation to perform before prescribing contraception?
In a 41‑year‑old woman with abnormal uterine bleeding (AUB) requesting contraception, what is the most appropriate investigation to perform before prescribing contraception?
In a 41-year-old woman seeking contraception with no abnormal uterine bleeding or menstrual irregularities, what is the most appropriate investigation before initiating contraception?
In a 6‑week pregnant woman with mild vaginal bleeding and an open cervical os, what is the most appropriate next step—repeat quantitative beta‑human chorionic gonadotropin (β‑hCG) in 24 hours, transvaginal ultrasound, or reassurance with re‑evaluation in 10 days?
What are the recommendations for measles, mumps, and rubella (MMR) vaccine administration in the elderly population?
Can Hydrochlorothiazide (HCTZ) cause hyponatremia?
Does hypothyroidism (underactive thyroid) cause paresthesia (numbness or tingling)?
What is the significance of a patient having a non-fasting (random) blood glucose level of 98 mg/dL and a non-fasting insulin level of 2.8 uU/mL?
What causes lumbar pain during pregnancy?
What are the differential diagnoses for a 26-year-old female with intermittent paresthesia (abnormal sensations) affecting her face, neck, and right upper and lower extremity, with a history of migraines with aura, who discontinued sumatriptan (generic name) 8 months ago and has irregular menstrual cycles after stopping birth control?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.